Home » Topics » BioWorld

BioWorld
RSS

CYTOGEN BEGINS TRIALS OF CANCER TREATMENT

Aug. 13, 1992

EMISPHERE BEGINS ORAL DELIVERY SYSTEM TRIALS

Aug. 13, 1992

CEPHALON RAISES $45M FOR ALS TREATMENT

Aug. 13, 1992

STEM CELL SYSTEM ENTERS CLINIC

Aug. 13, 1992

AGRITOPE ACQUIRES REMAINING AGRIMAX SHARES

Aug. 13, 1992

ANTI-INFECTIVE LEADS ALPHA-BETA STRATEGY

Aug. 13, 1992

CAMBRIDGE NEURO TESTS BRAIN DAMAGE DRUG

Aug. 12, 1992

E. MERCK TO MARKET BIOSITE'S DRUG TEST

Aug. 12, 1992

JACOBS QUITS GI'S BOARD

Aug. 12, 1992

OSTEOTECH LICENSES ABTOX PLASMA TECHNOLOGY

Aug. 12, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...